Results 1 to 10 of about 316,749 (274)

Management of in-stent restenosis

EuroIntervention, 2022
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI procedures performed in current clinical practice. This State-of-the-Art review will primarily focus on the management of ISR but will begin by briefly discussing ...
Alfonso, Fernando, Coughlan, J. Coughlan, Giacoppo, Daniele, Kastrati, Adnan, Byrne, Robert Byrne   +4 more
openaire   +5 more sources

Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction

Revista Portuguesa de Cardiologia, 2019
Introduction: Stent restenosis remains a clinical challenge for patients with ischemic heart disease, since it is associated with repeated coronary interventions as well as higher hospitalization rates and medical costs.
Ibrahim Rencuzogullari, Yavuz Karabağ, Metin Çağdaş, Süleyman Karakoyun, Sabri Seyis, Mustafa Ozan Gürsoy, Mahmut Yesin, İnanç Artaç, Doğan İliş, İbrahim Halil Tanboğa   +9 more
doaj   +2 more sources

In-Stent Restenosis [PDF]

JACC: Basic to Translational Science, 2020
Anna Lena Lahmann, MD, Michael Joner, MD
semanticscholar   +6 more sources

A computational model of coronary arteries with in-stent restenosis coupling hemodynamics and pharmacokinetics with growth mechanics [PDF]

Scientific Reports
Despite advances in stent technology, in-stent restenosis remains a critical challenge following percutaneous coronary intervention. In this work, we propose a comprehensive fluid-solid computational model to simulate restenosis after drug-eluting stent ...
Anna Ranno, Kiran Manjunatha, Thore Koritzius, Ivo Steinbrecher, Norbert Hosters, Maximilian Nachtsheim, Pakhwan Nilcham, Nicole Schaaps, Anne Turoni-Glitz, Janina Datz, Alexander Popp, Kevin Linka, Felix Vogt, Marek Behr   +13 more
doaj   +2 more sources

Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review [PDF]

Zhongguo quanke yixue, 2023
As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve ...
AN Jingjing, WANG Xiaojuan, DENG Aiyun
doaj   +1 more source

A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients

Frontiers in Cardiovascular Medicine, 2022
PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng, Ying Zhao, Haiyan Wang, Jiayu Zhao, Xun Wang, Jianping Shi   +5 more
doaj   +1 more source

Coronary In-Stent Restenosis: JACC State-of-the-Art Review.

Journal of the American College of Cardiology, 2022
The introduction and subsequent iterations of drug-eluting stent technologies have substantially improved the efficacy and safety of percutaneous coronary interventions.
G. Giustino, A. Colombo, A. Camaj, K. Yasumura, R. Mehran, G. Stone, A. Kini, Samin K. Sharma   +7 more
semanticscholar   +1 more source

SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis

Journal of the Society for Cardiovascular Angiography & Interventions, 2023
Stent failure remains the major drawback to the use of coronary stents as a revascularization strategy. Recent advances in imaging have substantially improved our understanding of the mechanisms underlying these occurrences, which have in common numerous
L. Klein, S. Nathan, A. Maehara, J. Messenger, G. Mintz, Ziad A. Ali, J. Rymer, Yader Sandoval, Karim Al-Azizi, R. Mehran, S. Rao, A. Lotfi   +11 more
semanticscholar   +1 more source

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways

European Heart Journal Open, 2023
Percutaneous coronary intervention (PCI) has evolved significantly over the past four decades. Since its inception, in-stent restenosis (ISR)—the progressive reduction in vessel lumen diameter after PCI—has emerged as the main complication of the ...
F. Pelliccia, M. Zimarino, G. Niccoli, D. Morrone, G. De Luca, F. Miraldi, R. de Caterina   +6 more
semanticscholar   +1 more source

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2022
: Advances in stent technology and the design of endovascular devices with thinner struts, anti‐inflammatory and antithrombotic polymers, and better drug kinetics have enhanced the safety and efficacy of the second‐generation drug‐eluting stents and ...
E. Erdoğan, Retesh Bajaj, A. Lansky, A. Mathur, A. Baumbach, C. Bourantas   +5 more
semanticscholar   +1 more source